Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A self-assembling ferritin nanoparticle-based trivalent vaccine of gB/gE/gH elicits potent immune responses against varicella-zoster virus.

International journal of biological macromolecules·2026
Same author

High-performance mid-wave infrared metasurface for broadband linear-to-circular polarization transformation.

Optics express·2025
Same author

The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation.

Journal of virology·2025
Same author

The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation.

PLoS biology·2025
Same author

Particle size-dependent neurotoxicity of microplastics in zebrafish (Danio rerio): Spatially resolved lipidomics links metabolic dysregulation to neurological disorders.

Journal of hazardous materials·2025
Same author

Development of an Assay Evaluating the Inducible HIV-1 Latent Reservoir Based on Reverse Transcription Droplet Digital PCR for Unspliced/Intact Viral RNA.

Journal of medical virology·2025
Same journal

High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.

Cell reports. Medicine·2026
Same journal

Microglial IL-27 modulates depression-like behaviors induced by postnatal immune activation.

Cell reports. Medicine·2026
Same journal

Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinoma.

Cell reports. Medicine·2026
Same journal

Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cells.

Cell reports. Medicine·2026
Same journal

Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors.

Cell reports. Medicine·2026
Same journal

Advancing CAR-NK cell therapy in solid tumors: Current landscape and future directions.

Cell reports. Medicine·2026
查看所有相关文章

相关实验视频

Updated: Jun 23, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.1K

开发PCSK9向的纳米粒子疫苗,有效降低高胆固醇血清症.

Qiannan Fang1, Xinyu Lu2, Yuanqiang Zhu3

  • 1Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.

Cell reports. Medicine
|June 19, 2024
PubMed
概括
此摘要是机器生成的。

一种针对PCSK9 (proprotein convertase subtilisin/kexin type 9) 的新型纳米粒子疫苗有效降低胆固醇并减少动脉样硬化. 这种创新的疫苗显示出治疗高胆固醇血症和相关心血管疾病的前景.

关键词:
这就是LDLR的LDLR.在PCSK9中毛囊的T细胞帮助细胞.超高胆固醇血症是一种高胆固醇血症.纳米颗粒疫苗的使用方法

更多相关视频

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K

相关实验视频

Last Updated: Jun 23, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.1K
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K

科学领域:

  • 心血管研究研究心血管研究
  • 免疫学 免疫学 免疫学
  • 纳米医学是一种纳米医学.

背景情况:

  • 蛋白转化酶亚素/素9型 (PCSK9) 在调节低密度脂蛋白受体 (LDLR) 降解方面发挥着关键作用,导致LDL胆固醇升高.
  • 升高的LDL胆固醇是动脉样硬化和心血管疾病的主要危险因素.
  • PCSK9已成为管理高胆固醇血症的重要治疗点.

研究的目的:

  • 开发和评估一种针对PCSK9.9的新型纳米粒子 (NP) 疫苗.
  • 在临床前模型中评估疫苗在降低血清脂质和减轻动脉样硬化的有效性.
  • 阐明疫苗治疗作用背后的免疫和细胞机制.

主要方法:

  • 将PCSK9的催化域与自组装的24-米尔费里NP结合,以创建PCSK9 NP疫苗.
  • 在高脂肪饮食引起的高胆固醇血症和AAV-hPCSK9引起的高胆固醇血症小鼠模型中对疫苗的评估.
  • 在相关的小鼠模型中评估动脉样硬化斑块负担和巨细胞透.
  • 研究T毛囊辅助细胞和LDLR在疫苗疗效中的作用.

主要成果:

  • PCSK9 NP疫苗成功诱导了针对PCSK9的干扰抗体.
  • 在这两种高胆固醇血清模型中都观察到血清脂质水平的显著降低.
  • 该疫苗显著减少了动脉样硬化斑块区域和大动脉中的巨细胞透.
  • 疫苗的有效性被证明取决于T毛囊辅助细胞和LDLR.

结论:

  • 开发的PCSK9 NP疫苗是对高胆固醇血症的有希望的免疫治疗策略.
  • 这种新型疫苗在临床前模型中有效降低了动脉样硬化进展.
  • 这些发现支持PCSK9 NP疫苗作为心血管疾病新疗法的潜力.